Sign In
About ASHM | Careers | Your Cart Shoppint Cart
Skip Navigation LinksASHM Internet Home > Videx and some Zerit treatment to be deleted

Videx and some Zerit treatment to be deleted

News |
HIV |
Nurses; Pharmaceutical Industry; Prescribers; GPs |
National |
  |
ASHM |
  |
  |
Bristol-Myers Squibb has advised that they are deleting HIV antiretroviral medication:  Videx (didanosine) 125 mg and 200 mg capsules; Zerit (Stavudine) 20mg capsules.

Videx_Zerit 600px.jpg


30 August 2016:  Bristol-Myers Squibb has advised that they are deleting  HIV antiretroviral medication:

    • Videx (didanosine) 125 mg and 200 mg capsules. Supply will continue until the existing stock has run out.
    • Zerit (Stavudine) 20mg capsules. Supply of 30 mg and 40 mg will remain unaffected. The 20mg stock will continue until supply runs out.

This decisions was taken on the basis of declining demand and the existence of therapeutic alternatives.  For medical information please contact 1800 067 567. 

Please enter a valid E-mail.
This must match your colleagues E-mail.
Please enter your name.
Please enter a valid email.
This must match your email.